Compare PAM Mineral Tbk. (NICL) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
PAM Mineral Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? PAM Mineral Tbk. trades at Rp468 (market cap 5.19T, 46.38M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: PAM Mineral Tbk. is far larger — about 49.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| NICL | SCPI | |
|---|---|---|
Market Cap | 5.19T | 104.4B |
Volume | 46.38M | — |
Lot | 463.81K | — |
Turnover | 21.73B | — |
Average Price | 468.61 | — |
Value | 21.73B | — |
Indicative Equilibrium Price | 468 | — |
Indicative Equilibrium Volume | 1.83K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About PAM Mineral Tbk.
PT PAM Mineral Tbk (the Company) was established on January 15, 2008 based on Notarial Deed No. 32 of Edison Jingga, S.H., notary in Jakarta. The Company operates in two operational areas, namely in Southeast Sulawesi, Lameruru Village, Langgikima District, North Konawe Regency and Laroenai Village, Bungku Pesisir District, Central Sulawesi.
Read more on NICL →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
